期刊文献+

三维三步MTT法肿瘤药敏试验与芬丹明B法的比较 被引量:2

Comparison of three-dimensional and three-step MTT assay and sulforhodamine B assay for tumor chemosensitivity testing
下载PDF
导出
摘要 目的 :比较自创的三维三步MTT法 (3D3S MTT法 )与MTT法及芬丹明B法 (SRB法 )在肿瘤药敏试验中的价值。方法 :选用Hep G2、T 2 4和SKOV3三种细胞系和丝列霉素及阿霉素两种抗癌药 ,观察暴露于两种药物 3d后再培养不同时间 ,用上述三种方法测定的药敏结果。MTT法与SRB法计算肿瘤生长抑制率 (%TGI)的公式均是 :%TGI =[1 At Ac]× 1 0 0 % ;根据自建的表达MTT代谢的数学模型 ,3D3S MTT法计算 %TGI的公式是 :%TGI =1 { [lnAmax ln(Amax At) ] [lnAmax ln(Amax Ac) ] } 1 b × 1 0 0 %。结果 :三种方法测定的药物剂量 反应曲线均呈S型。MTT法测定的 %TGI要比SRB法和 3D3S MTT法测定的结果低 ,而MTT法测定的IC50 平均为SRB法和 3D3S MTT法测定结果的 3~ 5倍。而 3D3S MTT法测定的 %TGI及IC50 与SRB法测定的结果相近似。结论 :3D3S MTT法克服了MTT法测定肿瘤药敏所存在的 3~ 5倍的低估问题 ,与SRB法相比结果可靠 。 Objective:To comparethe value of self establishedthree dimensional and three step MTT assay (3D3S MTT assay), MTT assay and Sulforhodamine B (SRB) assay for tumor chemosensitivity testing Methods:Hep G2, T 24 and SKOV3 cell lineswereexposed to Adriamycin and Mitomycin C for 3 days with different further culture durationand then carried out the above three methods For MTT assay and SRB assay the equation to calculate the percentage of tumour growth inhibition (%TGI) is: %TGI=[1 A t /A c ]×100% According to the self establishedmathematical model, the equation for 3D3S MTT assay is: %TGI=1 {\[lnA max ln(A max A t )\]/\[lnA max ln(A max A c )\]} 1/b ×100% Results: S shaped drug response curves were showed in all the above three methods Comparison of the results of %TGIand IC 50 show that %TGIpredicted by MTT assay is lower than that by SRB assay or 3D3S MTT assay, and IC 50 predicted by MTT assay is in average 3 to 5foldsof that by SRB assay or 3D3S MTT assay %TGIand IC 50 predicted by 3D3S MTT assay is approximately the same value as predicted by SRB assay Conclusion:3D3S MTT assay is applicable for in vitro tumor chemosensitivity testing, which is a successful solution to the 3 to 5 foldsunderestimation of chemosensitivity of MTT assay compared with SRB assay
出处 《军医进修学院学报》 CAS 2002年第3期170-172,共3页 Academic Journal of Pla Postgraduate Medical School
基金 国家自然科学基金资助项目 ( 30 0 0 0 16 4)
关键词 三维三步MTT法 肿瘤 药敏试验 芬丹明B法 Thiazoles spectrophotometry drug screening assays,antitumor
  • 相关文献

参考文献8

  • 1[1]Morgan DM. Tetrazolium (MTT) assay for cellular viability and activity[J]. Methods Mol Biol,1998,79:179-183. 被引量:1
  • 2[2]Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays[J]. J Immunol Methods,1983, 65(1-2):55-63. 被引量:1
  • 3[3]Sieuwerts AM, Klijn JG, Peters HA, et al. The MTT tetrazolium salt assay scrutinized[J]. Eur J Clin Chem Clin Biochem, 1995,33(11):813-823. 被引量:1
  • 4[4]Fricker SP, Buckley RG. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents[J]. Anticancer Res,1996,16(6B):3755-3760. 被引量:1
  • 5[5]Chen CF, Hwang JM, Wu CH, et al. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs[J]. Chin Med J (Taipei),1990,46(1):7-16. 被引量:1
  • 6[6]Plumb JA, Milroy R, Kaye SB. Effects of the pH dependence of MTT bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay[J]. Cancer Res,1989,49(16):4435-4440. 被引量:1
  • 7[7]Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening[J]. J Natl Can-cer Inst,1990,82(13):1107-1112. 被引量:1
  • 8[8]Fricker SP, Buckley RG. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents[J]. Anticancer Res, 1996,16(6B):3755-3760 被引量:1

同被引文献55

  • 1张毅,沈炜明.MTT肿瘤药敏试验中培养基的选择[J].药学服务与研究,2004,4(3):269-271. 被引量:22
  • 2辛华雯,王润帮,杜光祖.MTT法在恶性肿瘤体外药物敏感试验中的临床应用[J].实用癌症杂志,1994,9(2):73-75. 被引量:25
  • 3马玉彦,王波,鄢德友,刘理,李殿俊,林英姬,娄阁,王惠增,陈国林.MTT法检测人实体瘤化疗敏感性的临床应用研究[J].实用肿瘤学杂志,1996,10(4):9-10. 被引量:13
  • 4Mosman T.Rapid colorimetric assay for cellular growth and survival:Application and cytotxicity assays [J].Immunol Me-thods,1983,65:55-63. 被引量:1
  • 5Bellamy WT.Prediction of response to drug therapy of cancer:a review of in vitro assays[J].Drugs,1992,44:689-691. 被引量:1
  • 6Candiano G,Ghiggeri GM,Gusmano R,et al.Reaction of 2-amino-2-deoxy-D-glucose and lysine:is of action and raceterion of 2-5-bis(tetrahydroxybutyf)pyrazine[J].Carbohydr Res,1988,184(12):67. 被引量:1
  • 7Hertel W,Boder GB,Kroin JS,et al.Eveafuation of the antitumor activity of gecitabine[J].Cancer Res,1990,50(14):4417. 被引量:1
  • 8Babu G,Parikh P,Fuloria J,et al.A 2-stage Phase Ⅱstudy of gemcitabin and cisplatin in unresectable hepatocellular carcinoma[J].Ann Oncol,2000,11(14):62. 被引量:1
  • 9Yang TS,Lin YC,Chen HM,et al. Phase Ⅱ study of gemcitabine in patients with advanced hepatocellular carcinoma[J].Cancer,2000,89(4):750-756. 被引量:1
  • 10Ulrich-Pur H,Kornek GV,Fiebiger W,et al.Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabin[J].Oncology,2001,60(4):313-315. 被引量:1

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部